Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: J Abnorm Psychol. 2016 Nov 3;126(1):76–88. doi: 10.1037/abn0000220

Table 5.

Multigroup Bifactor SEM for Examining Gender Difference in Structural Parameters

Model fit indices
Standardized estimate (SE)
Wald test χ2 (df)
χ2 (df) RMSEA CFI General BPD AAB
Age of onset: Alcohol 320.96 (232)*** .023 .987 Female −.18a (.07) −.16 (.08) −.17a (.07) 2.55 (3)
Male −.12a (.04) −.16a (.07) −.33a (.06)
Age of onset: Drugs 329.06 (232)*** .024 .986 Female −.31a (.06) −.02 (.09) −.22a (.08) 7.17 (3)
Male −.13a (.05) −.17a (.07) −.35a (.06)
Total time spent in jail 324.43 (232)*** .024 .987 Female .10 (.06) −.02 (.08) .20a (.07) 7.59 (3)
Male −.03 (.05) .08 (.07) .47a (.06)
Lifetime Major Depressive Disorder 312.92 (232)*** .022 .989 Female .41a (.07) .52a (.09) .10 (.09) 1.92 (3)
Male .37a (.06) .66a (.08) .08 (.07)
Lifetime Anxiety Disorder 319.14 (232)*** .023 .988 Female .37a (.08) .41a (.10) .02 (.10) .38 (3)
Male .35a (.07) .39a (.09) −.04 (.09)
Lifetime Alcohol Dependence 337.08 (236)*** .025 .985 Female .43a (.06) 1.05 (1)
Male .34a (.05)
Lifetime Cannabis Dependence 318.22 (236)*** .022 .988 Female .28a (.08) .77 (1)
Male .20a (.05)
Lifetime Hallucinogens Dependence 337.49 (236)*** .025 .985 Female .19a (.08) 1.31 (1)
Male .30a (.06)
Lifetime Heroin/Opiates Dependence 355.99 (236)*** .027 .983 Female .03 (.07) 3.87 (1)
Male .21a (.05)
Lifetime Crack/Cocaine Dependence 344.47 (236)*** .026 .984 Female .32a (.07) .28 (1)
Male .28a (.05)
Lifetime history of psychiatric treatment 311.85 (232)*** .022 .989 Female .31a (.07) .58a (.09) .23a (.09) 8.97 (3)
Male .12 (.06) .54a (.09) .06 (.07)
Lifetime history of drug and alcohol treatment 328.92 (232)*** .024 .986 Female .04 (.08) .30a (.10) .34a (.10) 3.19 (3)
Male .09 (.06) .08 (.10) .17a (.08)

Note: General = general factor; BPD = BPD group specific factor; AAB = AAB group specific factor;

***

p < .001

**

p < .01.

a

Denotes standardized estimates falling within the 95% CI.